is semaglutide bad for you Can Cut in Half? Safety and Dosing Facts FDA Warns on Certain Forms

Both are part of a booming class of medications often grouped under the umbrella of GLP-1 drugs, which roughly 12% of Americans including about 1 in 5 women over 50 have used for weight loss or diabetes management

CON, n = 6)

GLP-1 receptor agonist therapy should be considered in all patients with type II diabetes and elevated ASCVD risk regardless of A1c or current hyperglycemic therapy

Am J Clin Exp Immunol (2018) 7:506

Image Credit: Love Employee / Shutterstock In a recent study published in the journal Communications Medicine , a group of researchers examined associations between initiation of tirzepatide or semaglutide and incident neuropsychiatric diagnoses in adults with obesity, compared with other weight-loss treatments, with separate analyses for individuals with and without type 2 diabetes

What Is Medicaid